India Vaccine Market to Grow at a CAGR of 8.8% During 2024-2032, Aided by the Rising Prevalence of Infectious Diseases in the Region

India Vaccine Market Overview

A vaccine refers to a biological preparation designed to deliver active acquired immunity against a specific infectious or malignant disease. These products train the immune system to generate antibodies to fight against serious and often deadly diseases. The rising burden of infectious diseases and growing recognition of the benefits of vaccination are contributing to the market demand. Further, the increasing public-private partnerships and the presence of robust regulatory support are poised to bolster the market growth. Moreover, an increase in the government programs that enable routine immunization of newborns and children is projected to impact the market dynamics.

Key Findings

• In February 2023, Gavi (the Global Alliance for Vaccines and Immunization) and the Government of India renewed their strategic partnership, under which Gavi will offer funding worth USD 250 million to reach children who have not received even a single routine vaccine shot and also generate stronger demand for vaccines in India. Such partnerships aimed at boosting routine immunization across the country are set to fuel market growth.
• In August 2024, the first-ever Phase 3 clinical trial for a dengue vaccine called DengiAll developed by Panacea Biotec, a leading India-based vaccine maker, was initiated by the company in partnership with the Indian Council of Medical Research (ICMR). It involved 19 sites in 18 states and Union Territories. The rise in the clinical development of such indigenous vaccines is a major market trend.
• The growing public awareness of infectious diseases along with the rising advancements in the development of new vaccines and improvements in the existing ones are likely to elevate the market value.

India Vaccine Market Demand Drivers

Infectious diseases pose a significant challenge to public health in India due to factors such as poor sanitation and lack of clean drinking water. Recent data reveals around 1.2 billion people in India are prone to falling sick owing to communicable diseases. The increasing prevalence of infectious diseases, such as tuberculosis and malaria, is a key factor driving the demand for vaccines in India. Additionally, the growing focus on preventive healthcare and the rise in government awareness campaigns are leading to higher vaccination rates and are expected to augment the market demand in the forecast period.

India Vaccine Market Segmentation Analysis

The Type Segment is Poised to Witness Significant Market Growth in the Forecast Period

Based on type, the market segmentation includes monovalent and multivalent vaccines. Monovalent vaccines, such as the measles vaccine, consist of a single strain of a single antigen and thus protect against a single microorganism or antigen. On the other hand, multivalent vaccines comprise two or more serotypes of the same antigen and are often more protective and immunogenic compared to monovalent vaccines.

The market report also offers insights based on disease type, technology, patient type, route of administration, and end user.

India Vaccine Market: Competitive Landscape

• In March 2024, Indian multinational pharmaceutical company Dr. Reddy's Laboratories announced an exclusive distribution partnership with Sanofi Healthcare India to boost the availability of Sanofi’s vaccine brands such as Adacel, Hexaxim, and Tetraxim, across private markets in India.
• In April 2024, Serum Institute of India, a leading vaccine maker and subsidiary of Serum Institute Life Sciences (SILS), announced to double its equity investment in Biocon Biologics Limited (a subsidiary of Biocon Limited), pushing the total investment to USD 300 million.
• Other players involved in the market include GlaxoSmithKline Plc, Sanofi, Pfizer, Inc., Merck & Co. Inc., Bharat Biotech International Ltd, Panacea Biotec, Cadila Pharmaceuticals Ltd., Human Biological Institute, and Haffkine Bio-Pharmaceutical Corporation Ltd.

India Vaccine Market Analysis by Region

Northern Region of India Covers a Significant Market Share

The market report offers insight into various geographical locations in India, including North India, South India, East India, and West India. The Northern region of India is a major market for vaccines owing to the high population density in states like Uttar Pradesh and Rajasthan, propelling the demand for adult and pediatric vaccines. The rise in the number of government-funded immunization programs also supports the market expansion in the region. Moreover, the increasing focus on improving healthcare access and infrastructure is anticipated to bolster the market demand in the region.

Key Offerings of the Report

• The EMR report gives an overview of the Indian market for vaccines for the time span of (2017-2023) and (2024-2032).
• The report also offers historical (2017-2023) and forecast (2024-2032) market information for the disease type, technology, type, patient type, route of administration, and end-user of the market.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790